Current and Perspective Diagnostic Techniques for COVID-19.
Betacoronavirus
/ chemistry
COVID-19
CRISPR-Cas Systems
Coronavirus Infections
/ diagnosis
Cytopathogenic Effect, Viral
Fluorescence Resonance Energy Transfer
/ methods
Humans
Immunochemistry
/ methods
Molecular Diagnostic Techniques
/ methods
Nucleic Acid Amplification Techniques
/ methods
Pandemics
Pneumonia, Viral
/ diagnosis
RNA, Viral
/ genetics
Reverse Transcriptase Polymerase Chain Reaction
/ methods
SARS-CoV-2
Spectrum Analysis, Raman
/ methods
Tomography, X-Ray Computed
/ methods
Whole Genome Sequencing
/ methods
COVID-19
SARS-CoV-2
biosensors
diagnostics
immunoassay
molecular diagnostics
Journal
ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580
Informations de publication
Date de publication:
14 08 2020
14 08 2020
Historique:
pubmed:
18
7
2020
medline:
29
8
2020
entrez:
18
7
2020
Statut:
ppublish
Résumé
Since late December 2019, the coronavirus pandemic (COVID-19; previously known as 2019-nCoV) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been surging rapidly around the world. With more than 1,700,000 confirmed cases, the world faces an unprecedented economic, social, and health impact. The early, rapid, sensitive, and accurate diagnosis of viral infection provides rapid responses for public health surveillance, prevention, and control of contagious diffusion. More than 30% of the confirmed cases are asymptomatic, and the high false-negative rate (FNR) of a single assay requires the development of novel diagnostic techniques, combinative approaches, sampling from different locations, and consecutive detection. The recurrence of discharged patients indicates the need for long-term monitoring and tracking. Diagnostic and therapeutic methods are evolving with a deeper understanding of virus pathology and the potential for relapse. In this Review, a comprehensive summary and comparison of different SARS-CoV-2 diagnostic methods are provided for researchers and clinicians to develop appropriate strategies for the timely and effective detection of SARS-CoV-2. The survey of current biosensors and diagnostic devices for viral nucleic acids, proteins, and particles and chest tomography will provide insight into the development of novel perspective techniques for the diagnosis of COVID-19.
Identifiants
pubmed: 32677821
doi: 10.1021/acsinfecdis.0c00365
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM